41 results about "Oil Dosage Form" patented technology

An abuse deterrent immediate release biphasic matrix solid dosage form that releases the drug at a desired rate for quick onset of action when a single unit or prescribed units of the dosage form are orally administered but exhibits a reduced rate of release when more than the prescribed number of units, are administered.

Provided herein are controlled release oral dosage forms of poorly soluble drugs, methods of making the dosage forms, and methods of their use for the treatment of various diseases and / or disorders.

An abuse deterrent immediate release coated reservoir solid dosage form that releases the drug at a desired rate for quick onset of action when a single unit or prescribed units of the dosage form are orally administered but exhibits a reduced rate of release when more than the prescribed number of units, are administered.

An orally administered dosage form that facilitates delivery of an agent locally in the buccal cavity for a sustained period of time includes mucoadhesive particles that are made of at least a mucoadhesive material combined with the agent, and which are dispersed in a disintegrating film. The dosage form is capable of delivering an agent to a patient at the desired oral mucosa site over an extended period of time while reducing patient discomfort or annoyance associated with conventional sustained release mucoadhesive films that must reside on the oral mucosa during the period of sustained release.

Solid pharmaceutical dosage form for the release of nicotine in the oral cavity comprising a core encapsulated by at least one film coating, wherein the core comprises nicotine and wherein the film coating comprises at least one film-forming polymer and at least one component for reduction of one or more organoleptically disturbing sensations, and where the at least one film coating is devoid of nicotine and devoid of buffer.

The invention relates to an oral dosage form, comprising at least one biologically active agent, formulation auxiliary substances and magnetizable particles, wherein the dosage form has an at least two phase composition, wherein the phases can dissolve in the body after oral administration due to their formulation and the magnetizable particles are bound in formulation auxiliary substances and are present in a magnetized state, wherein the magnetized particles are present in at least two phases of the dosage form and generate magnetic fields, wherein these phases dissolve at different times in the body after oral administration, and wherein the magnetic field strength with respect to time, position and movement in the body is acquired using a detection system and can be evaluated using a computer-based evaluation system.

The invention relates to a pharmaceutical preparation taking levorotatory gossypol as active ingredient, in particular to a compound preparation which contains the medicine such as levorotatory gossypol, potassium chloride, vitamin B1 and vitamin B6, etc. and is used for curing gynecological disease. The compound preparation comprises an oral solid preparation and an injection.

The invention discloses an insecticidal composition containing pyriminostrobin and hexythiazox. The insecticidal composition is characterized in that the active ingredients of the insecticidal composition are pyriminostrobin and hexythiazox; the weight ratio of pyriminostrobin to hexythiazox is (1:5)-(10:1). The composition can be prepared into the dosage forms such as suspension concentrates, wettable powder, water dispersible granules, dispersible oil suspension concentrates, microemulsion or emulsifiable concentrates. The insecticidal composition has the advantages that the insecticidal composition has reasonable components and good acaricidal effects; the activity and acaricidal effects of the insecticidal composition are not simple superposition of the activities of the components; compared with existing single preparations, the insecticidal composition has obvious synergistic effects besides obvious insecticidal effects, has good safety to crops and has obvious control effects on Panonychus citfi McGregor, Panonychus ulmi or Tetranychus cinnabarinnum Boisduval.

This invention provides a controlled dosage form-dispensing device, comprising a multi-chamber, bulk medicine storage and distribution unit, wherein said unit is provided with a plurality of individual dosage form-containing storage chambers with respective delivery ports; and a personal medication dispenser comprising a fixed dosage form extracting station comprising a dosage form receiving and extracting mechanism; wherein the medication dispenser is provided with a controller which moves the bulk medicine storage and distribution unit sequentially bringing a respective delivery port of a predetermined chamber into register with the fixed dosage form extracting station such that the dosage form receiving and extracting mechanism extracts and receives only one dosage form at a time. The dispensing device is further provided with at least one portable dosage form-dispensing cassette having a plurality of compartments and a first delivery controller for delivery of a predetermined dosage form from a predetermined compartment of the portable dosage form-dispensing cassette, the at least one portable cassette being releasably attachable to a personal medication dispenser; and a second delivery controller for the controlled delivery of predetermined dosage forms from the multi-chamber, bulk medicine storage and distribution unit to the portable dosage form-dispensing cassette via a conduit in the personal medication dispenser.

Provided herein are controlled release oral dosage forms of poorly soluble drugs, methods of making the dosage forms, and methods of their use for the treatment of various diseases and / or disorders.

The present invention generally relates to dosage forms for oral administration including one or more gelling agents. In particular, the present invention is directed to gelling agent-based dosage forms that are easily administered and taken, or swallowed. The present invention is also directed to gelling agent-based dosage forms that exhibit relatively low syneresis, are thermally stable, exhibit substantially constant active ingredient concentration, and / or exhibit one or more advantageous rheological properties. In particular, the present invention is directed to such gels containing one or more omega-3 fatty acids. The gelling agent-based dosage forms of the present invention are suitable for administration of a relatively large dose of active ingredient. The gelling agent-based dosage forms of the present invention are also suitable for administration of multiple active ingredients. Dosage forms of the present invention also provide tamper resistance and, thus, prevent recovery or diversion of active ingredients contained therein. The gelling agent-based dosage forms are also suitable for use as gastro-retentive and sustained release dosage forms.

The invention provides an avermectin-containing pesticide in the dosage form of missible oil. An active ingredient of the pesticide is avermectin. Formula of the pesticide contains the following components, by weight, 20% of flutenzine, 8% of avermectin, 1% of an emulsifier, 1% of a solvent, 1% of a cosolvent and deionized water added to 100%. Avermectin has good synergism. The pesticide provided by the invention has advantages of synergistic effect, low use cost, good control effect, wide acaricidal spectrum, high adaptability, long persistent period, low toxicity, low residue content, good safety and high compatibility, and can be used for killing both egg and larvae.